MLL-containing complexes methylate histone H3 at lysine 4 (H3K4) and have been implicated in the regulation of transcription. However, it is unclear how MLL complexes are targeted to specific gene loci. Here, we show that the MLL2 complex associates with the hematopoietic activator NF-E2 in erythroid cells and is important for H3K4 trimethylation and maximal levels of transcription at the b-globin locus. Furthermore, recruitment of the MLL2 complex to the b-globin locus is dependent upon NF-E2 and coincides spatio-temporally with NF-E2 binding during erythroid differentiation. Thus, a DNA-bound activator is important initially for guiding MLL2 to a particular genomic location. Interestingly, while the MLL2-associated subunit ASH2L is restricted to the b-globin locus control region 38 kb upstream of the b maj -globin gene, the MLL2 protein spreads across the b-globin locus, suggesting a previously undefined mechanism by which an activator influences transcription and H3K4 trimethylation at a distance.
INTRODUCTION
Developmentally regulated patterns of gene expression are established through the opposing function of trithorax (TrxG) and polycomb (PcG) group proteins (Ringrose and Paro, 2004) . PcG proteins have been shown to maintain a repressive chromatin structure, whereas TrxG proteins act to establish a chromatin structure permissive for transcription. Although the exact mechanism by which these complex patterns of gene expression are established is unclear, epigenetic modification of histones appears to play an important role (Ringrose and Paro, 2004) . Of particular interest, specific methylation events at histone H3 mark chromatin for either transcriptional activation or repression-methylation of histone H3 at lysine 4 (H3K4) marks genes located in an open chromatin structure, whereas methylation at lysine 9 and/or 27 target transcriptionally repressed genes (Margueron et al., 2005; Martin and Zhang, 2005; Ruthenburg et al., 2007; Shilatifard, 2006) . In mammals, H3K4 methylation is mediated by the SET1 family of TrxG proteins, which includes four related MLL (mixed lineage leukemia)-like methyltransferases. All MLL-like proteins associate with an overlapping set of regulatory subunits to form the MLL complexes (Ruthenburg et al., 2007) . Although all core subunits are important for regulating the H3K4 methyltransferase activity, the TrxG protein ASH2L seems to be required for H3K4 trimethylation (H3K4me3) (Dou et al., 2006; Steward et al., 2006) , a modification that, in contrast to mono-and dimethylation, is strictly correlated with active genes in vivo (Bernstein et al., 2005) . Despite extensive study, the mechanism that permits targeting of MLL complexes to gene loci has remained elusive (Slany, 2005) . On one hand, MLL-like proteins interact with sequence-specific DNA-bound transcription factors (i.e., p53, Max, E2F6 [Dou et al., 2005] , estrogen receptor [Mo et al., 2006] , retinoic acid receptor [Goo et al., 2003] , and LEF-1/TCF [Sierra et al., 2006] ), suggesting a gene-targeting mechanism through interactions with cell-specific DNA-bound transcription factors. On the other hand, several studies have reported an interaction between MLL and the Ser5-phosphorylated form of RNA polymerase II (Ser5P-Pol II) (Hughes et al., 2004; Milne et al., 2005a) , suggesting that recruitment of MLL-like proteins could occur via interaction with the elongating Pol II. Consistent with this possibility, the genomic distribution of the H3K4me3 mark overlaps that of the early elongating Pol II (Milne et al., 2005a; Ng et al., 2003) .
Here, we report the first study investigating the recruitment mechanism of a MLL2-containing methyltransferase complex to the b-globin locus during terminal erythroid differentiation. We show that the MLL2 complex associates with the hematopoietic activator NF-E2 in erythroid cells and is recruited to the b-globin locus in a NF-E2-dependent manner. This suggests that a DNA-bound activator is important initially for guiding MLL2 to a specific region of the genome. Interestingly, although recruitment of the MLL2 complex is limited to the b-globin locus control region (LCR) located 38 kb upstream of the active b maj -globin gene (Hardison et al., 1997) , the MLL2 protein spreads across the b-globin locus. Importantly, this spreading increases during erythroid differentiation, suggesting a mechanism by which a distal activator influences transcription and chromatin structure far downstream of its binding site. Finally, MLL2 is fully activated only when it reaches the coding region of the active b maj -globin gene, because trimethylation of H3-K4 is restricted to this part of the locus.
RESULTS

NF-E2 Interacts with the Histone H3K4 Methyltransferase Complex MLL2
The murine b-globin locus is comprised of four clustered b-like globin genes, which are transcribed at specific developmental stages and only in erythroid cells (Hardison et al., 1997) . Of particular interest is the hematopoietic transcriptional activator NF-E2/p45 (Andrews, 1998) , which is required for erythroid differentiation and b-globin activation in mouse erythroleukemia (MEL) cells and has been implicated in mediating H3K4 dimethylation at the b-globin locus (Kiekhaefer et al., 2002 (Kiekhaefer et al., , 2004 . To decipher the mechanism by which NF-E2/p45 activates b-globin transcription at a distance, we used immunoprecipitation (IP) to purify cofactors associating with the endogenous NF-E2/p45 protein from erythroid cells. Numerous proteins (currently under investigation) coimmunoprecipitate with NF-E2/p45 in a specific manner. Among them, several subunits of the MLL complexes were identified by quantitative mass spectrometry, including WDR5 (identification score 100%) and HCF1 (identification score 100%). Furthermore, HCF1, WDR5, and ASH2L were detected in our previous mass spectrometry study of proteins interacting with the NF-E2/p45-dimerization partner MAFK (Brand et al., 2004 , and data not shown). These three proteins, ASH2L, WDR5, and HCF1, are conserved subunits of the MLL methyltransferase complexes (Ruthenburg et al., 2007) . Western blots were performed to confirm these interactions and to determine whether NF-E2 also associates with other subunits of the MLL complexes. We detected five conserved subunits of MLL complexes in the elution of the NF-E2/p45 IP ( Figure 1A ), including ASH2L, WDR5, and RbBP5, which constitute the structural core of the complex (Dou et al., 2006) and the tumor suppressor MENIN, previously found in related methyltransferase complexes containing ASH2L (Hughes et al., 2004; Yokoyama et al., 2004) . Interestingly, by using several independently raised Abs, we could not detect MLL1 in the NF-E2/p45 IP, even though this gene is transcribed in MEL cells (not shown). However, we were able to show an interaction of NF-E2/p45 with its close homolog MLL2/ TRX2 (also called MLL4) ( Figure 1A) . Importantly, MLL1 and MLL2 display a high degree of similarity resulting from gene duplication (FitzGerald and Diaz, 1999) . To further confirm the association of NF-E2/p45 with the MLL2 complex, we performed reciprocal IPs with Abs against the endogenous MLL2 and ASH2L proteins in erythroid nuclear extracts. Both subunits of the NF-E2 complex (MAFK and p45) were detected in the MLL2 and ASH2L IPs ( Figures 1A and 1B) , confirming the association of the activator NF-E2 with the MLL2 complex in differentiated erythroid cells. Notably, the acetyltransferase p300/CBP was also identified in the MLL2 and NF-E2/p45 IPs, consistent with previously published data (Ernst et al., 2001; and Brand et al., 2004; Hung et al., 2001, respectively) . Interaction with this acetyltransferase has been shown to be important for the function of both MLL1 (Popovic and Zeleznik-Le, 2005) and NF-E2/p45 (Hung et al., 2001) .
To determine whether the MLL2 complex associating with NF-E2 is active, NF-E2-interacting proteins isolated on beads were used to perform an in vitro methylation assay with either purified or nucleosomal histones as a substrate. We found that NF-E2-associated proteins specifically methylate histone H3 in both free and nucleosomal contexts ( Figure 1C ). Furthermore, 11 amino acid peptides corresponding to the N-term part of histone H3 that are either wild-type, acetylated, or mutated at position 9 are efficiently methylated by NF-E2-associated proteins. Meanwhile, a peptide trimethylated at H3K4 is a poor substrate for methylation by these proteins ( Figure 1D ). In combination, these results demonstrate that H3K4 is the methylation site of NF-E2-associated proteins.
The MLL2 Complex Is Recruited to the b-Globin Locus in a NF-E2-Dependent Manner To determine whether NF-E2 helps recruit the MLL2 complex to the b-globin locus, we used Abs recognizing ASH2L and MLL2 to perform chromatin immunoprecipitations (ChIPs) in the NF-E2/p45 null murine erythroleukemia cell line CB3 (Kotkow and Orkin, 1995; Lu et al., 1994) and in a rescued CB3 cell line expressing exogenous NF-E2/ p45 in which b-globin transcription is partially restored (Figures 2A and 2B ). We observed that ASH2L and MLL2 are not bound to the b-globin locus control region (LCR) in the NF-E2 null CB3 cell line whereas they are recruited to this site upon re-expression of NF-E2/p45 ( Figure 2D ). Thus, the MLL2 complex is recruited to the b-globin locus in a NF-E2-dependent manner. In addition, it has been shown that Ser5P-Pol II is bound to the LCR in the absence of NF-E2/p45 in CB3 cells (Johnson et al., 2001) , which eliminates the possibility that the MLL2 complex could be recruited indirectly through an interaction between NF-E2 and Pol II.
To further analyze the recruitment of the MLL2 complex to the b-globin locus during erythroid differentiation, we used MEL cells, which can be induced to undergo most subsequent steps of normal erythroid differentiation, including a greater than 100-fold activation of b-globin transcription (Sawado et al., 2001 ). ASH2L and MLL2 binding were analyzed by ChIP before and after induction of erythroid differentiation in MEL cells (Figure 3 ). TaqMan probes recognizing 14 sequences located within representative regions of the b-globin locus (e.g., upstream of the LCR, at the LCR, within the inactive Ey and bH1 genes, within the active b maj -globin gene and at locations between these genes; Figure 3A ) were used to detect the binding of NF-E2/p45, ASH2L, and MLL2 by quantitative PCR (qPCR). Consistent with previous results (Brand et al., 2004; Forsberg et al., 2000; Sawado et al., 2001) , we observed that during differentiation, NF-E2/p45 is recruited primarily to the HS2 site of the LCR, where NF-E2-DNA binding sites are located ( Figure 3B ). In addition, we found that ASH2L, MLL2, and the DPY-30 subunit of the MLL2 complex are also recruited to the b-globin locus during erythroid differentiation ( Figure 3B and data not shown). Interestingly, whereas recruitment of ASH2L and DPY-30 parallels that of NF-E2/p45 (mostly limited to the (D) 11 amino acid peptides corresponding to the N-term part of histone H3 that are either wild-type (WT), acetylated at lysine 9 (AcK 9 ), mutated at position 9 (K/A 9 ), or mutated at lysine 9 and trimethylated at lysine 4 (K 4 me3-K/A 9 ) were used as a substrate for methylation by NF-E2/p45-, mock-, or MLL2-associated proteins and the radioactivity was counted (in cpm) after a filter binding assay. Error bars correspond to the standard deviation of 3 counts of 1 min each. The experiment was performed at least twice independently.
LCR), binding of MLL2 after differentiation extends well beyond the LCR, spanning the entire b-globin locus ( Figure 3B and data not shown). This enrichment profile is reminiscent of MLL1 binding to active genes (Guenther et al., 2005; Scacheri et al., 2006) in that it is more prominent within the 5 0 coding region of the b maj -globin gene (exon 2). Furthermore, our detailed analysis of MLL2 binding across the b-globin locus reveals that MLL2 is also recruited to additional regions outside the gene coding area and the LCR, including the region upstream of the LCR and the intervening region between the LCR and the active b maj -globin gene, which spans the two inactive embryonic/fetal b-like globin genes Ey/ bH1. In contrast, MLL2 does not bind to the inactive muscle-specific gene myogenin. Although we note that the MLL2 binding signal is lower in areas outside the LCR and the b maj -globin gene, it is still significant and specific. Indeed, the signals are $20-fold higher than on the myogenin control. In addition, MLL2 binding increases significantly during erythroid differentiation ( Figure 3B ) and is further reduced in response to MLL2 knockdown ( Figure S1 in the Supplemental Data available online). Therefore, our results suggest a mechanism in which the methyltransferase MLL2 spreads across the b-globin locus during terminal erythroid differentiation. The apparent increased binding of MLL2 at the LCR and the active b maj -globin gene may result from MLL2 ''stalling'' in specific areas of the b-globin locus and more efficient spreading in others, perhaps dependent on different chromatin architectures.
H3K4me3 and H3K9ac Are Restricted to the 5
0 Region of the Active b maj -Globin Gene Having shown that the MLL2 H3K4 methyltransferase is recruited to the b-globin locus, we next used ChIP to examine whether the H3K4me3 mark is enriched within this locus during erythroid differentiation ( Figure 4A ). A strong increase of H3K4me3 was detected after erythroid differentiation within a restricted area of the b maj -globin gene coding region (exon 2, $400 bp downstream of the transcription start site). Exon 3 (located 1 kb downstream of the transcription start site) also displays an increase in H3K4me3 during differentiation, although to a lesser extent than exon 2 ( Figure 4A ). This overall pattern of H3K4me3 enrichment within the 5 0 coding region is similar to that reported for other active genes (Bernstein et al., 2005; Schneider et al., 2004) . Interestingly, during differentiation we did not observe an increase in H3K4me3 directly at the promoter or at the +80 bp region corresponding to exon 1. Instead, the strong increase in H3K4me3 starts after the first 80 bp within the transcribed region of the gene where Pol II is already switched to the elongation mode (Sims et al., 2004) . This further suggests that H3K4me3 is linked to transcriptional elongation after promoter clearance. Finally, the LCR and the region between the LCR and the active b maj -globin gene is devoid of H3K4me3 before and after erythroid differentiation (Figure 4A) . Thus, even though MLL2 is present at the LCR and in the region between the LCR and the b maj -globin gene ( Figure 3B ), it is not sufficient to methylate H3K4, suggesting that additional events are required to activate MLL2 methyltransferase activity at the b maj -globin gene. Alternatively, active demethylation of H3K4 could be taking place at the LCR and the intervening regions.
Interestingly, large-scale mapping of histones modifications revealed a strong correlation between the distribution of H3K4me3 and H3K9ac/H3K14ac across the human chromosomes 21 and 22 (Bernstein et al., 2005) . Furthermore, a crosstalk between H3K4me3 and H3K9ac has previously been described (reviewed in Margueron et al., 2005) . Thus, we examined the enrichment of the H3K9ac mark across the b-globin locus by ChIP during differentiation (Figure 4) . We found that H3K9ac profile indeed parallels that of H3K4me3 across the locus, whereby the 5 0 region of the b maj -globin gene open reading frame becomes highly enriched for these modifications after differentiation ( Figure 4B ). This suggests that MLL2 methyltransferase activity could be triggered by the H3K9ac mark when reaching the coding region of the b maj -globin gene. Interestingly, it has recently been suggested that the repressive H3K9me3 mark is present within the transcribing b maj -globin gene (Kim et al., 2006; Vakoc et al., 2005) . However, H3K9ac and H3K9me3 modifications are mutually exclusive whereas H3K9me3 and H3K4me3 inhibit each other in vitro ) and do not correlate on other genes in vivo (Vakoc et al., 2006) . This suggests that the active (H3K4me3/H3K9ac) and repressive (H3K9me3) states exist in a dynamic equilibrium on the b-globin locus, and that a shift toward the active state may result in high-level transcription of the b maj -globin gene during erythroid differentiation.
ASH2L and MLL2 Knockdowns Lead to a Decrease in H3K4me3 and b-Globin Transcription
It has been shown previously that knockdown (KD) of various subunits of MLL complexes result in a 20% to 40% decrease in transcription and a 40% to 60% reduction of H3K4me3 on some Hox genes (Dou et al., 2006) . This mild transcriptional defect might be due to small amounts of proteins remaining after the KD and/or to the possibility that MLL complexes might not be required for initiating transcription (Pavri et al., 2006) but instead for increasing the rate of transcriptional elongation (Margueron et al., 2005; Shilatifard, 2006) . Because of the apparent divergence between ASH2L and MLL2 binding profiles with H3K4me3 enrichment at the b-globin locus, it was important to determine whether these proteins are involved in H3K4 trimethylation and b-globin transcription during erythroid differentiation. Thus, we used RNA interference (RNAi) to knock down either ASH2L or MLL2 proteins in MEL cells, and we analyzed the resulting effects on b-globin transcription and H3K4 trimethylation. Stable MEL clones expressing a doxycycline (Dox)-inducible anti-ASH2L or -MLL2 small hairpin RNA (shRNA) constructs were derived and selected by western blot with anti-ASH2L and -MLL2 polyclonal Abs ( Figure 5A ). The parent and ASH2L and MLL2 KD MEL clones were induced to differentiate for 3 days in the presence/ absence of Dox. Although the KDs have no effect on cell growth (not shown), we observed a 30% decrease in the production of b-globin mRNA transcripts after erythroid differentiation after the ASH2L KD and a 60% decrease after induction of the MLL2 KD by Dox treatment ( Figure 5B ). These transcriptional defects were accompanied by a significant decrease in hemoglobin production (not shown). In contrast, Dox has no effect on b-globin transcription in the parent MEL cell line. Importantly, H3K4me3 ChIPs in the KD cells also revealed a 20% and 30% decrease in H3K4me3 within the b maj -globin coding region after ASH2L and MLL2 KD, respectively ( Figure 5C ). These results show that ASH2L and MLL2
are important for b-globin transcription and H3K4 trimethylation during erythroid differentiation. Furthermore, the level of reduction of b-globin transcripts and H3K4me3 is comparable to that observed for certain Hox genes after KD of MLL-associated proteins (Dou et al., 2006) . Finally, to determine whether the activator NF-E2/p45 is also important for H3K4 trimethylation, we performed H3K4me3 ChIP experiments in the NF-E2/p45 null CB3 cell line, and we observed that H3K4me3 on the b maj -globin gene is increased upon re-expression of the NF-E2/p45 activator in the erythroid CB3 cell line ( Figure 2C ). These results provide direct evidence that NF-E2-mediated recruitment of the MLL2 complex at the b-globin locus is important for both H3K4 trimethylation and transcription at the b-globin locus during erythroid differentiation.
DISCUSSION
Recruitment, Spreading, and Activation of the MLL2 H3K4 Methyltransferase at the b-Globin Locus during Erythroid Differentiation Our study provides evidence that a cell-specific DNAbound transcriptional activator is required for initial targeting of the MLL2 methyltransferase complex to a specific gene locus and further methylation of H3K4 at this locus. First, we show that the hematopoietic activator NF-E2/ p45 associates with the MLL2 methyltransferase complex in erythroid nuclear extracts and that this complex is recruited to the b-globin locus during erythroid differentiation in a NF-E2-dependent manner. Recruitment of the ASH2L/MLL2 complex occurs at the b-globin LCR, which contains cognate recognition sites for the activator and likely occurs independently of Pol II. Interestingly, we observed that whereas the ASH2L/MLL2 complex remains at the b-globin LCR during erythroid differentiation, the MLL2 subunit spreads across the b-globin locus, suggesting a mechanism by which a distal activator influences chromatin structure and transcription far downstream of its binding site (Figure 6 ). These results are supported by previous studies showing that ASH2L, RbBP5, and WDR5 can form a subcomplex in the absence of MLL (Dou et al., 2006; Steward et al., 2006) and by ChIP coupled with microarray experiments revealing that different subunits of MLL complexes bind separately to some genomic locations (Scacheri et al., 2006) .
The molecular mechanism by which MLL2 detaches from its interacting partner ASH2L and spreads across 38 kb of the b-globin locus is currently unclear but could involve MLL2 self-association through its SET domain (Rozovskaia et al., 2000) . Alternatively, it could entail combinatorial interactions with nonmethylated CpG DNA (Ayton et al., 2004) and/or specifically modified histones and cofactors, reminiscent of the spreading of HP1 through interaction with methylated H3K9 (Hiragami and Festenstein, 2005) . Whereas MLL2 appears to spread across the b-globin locus, our data suggest that additional regulatory mechanisms are required to activate its H3K4 methyltransferase activity at particular gene locations. Indeed, the H3K4me3 mark is restricted to a small region located around +400 bp downstream of the b maj -globin transcription start site, suggesting that at the other regions, trimethylation at H3K4 is either inhibited or actively removed. Within the 5 0 part of the b maj -globin gene coding region, MLL2 enzymatic activity is likely enhanced by combinatorial modification of histones (i.e., H3K9ac [ Figure 4 ]), phosphorylation of H3 (Rea et al., 2000) , and monoubiquitination of H2B (Dover et al., 2002; Sun and Allis, 2002) together with events associated with the early elongating Pol II (Hughes et al., 2004; Milne et al., 2005a ) and other interacting factors (i.e., the ubiquitin E3 ligases RNF20/40 and the E2 ubiquitin conjugating enzyme UbcH6 (Zhu et al., 2005b) , the elongation complex PAF (Zhu et al., 2005a) , and the histone chaperone FACT (Pavri et al., 2006 ) (see our model in Figure 6 ). Based on these results, we propose that interaction with a DNAbound activator is important initially for guiding MLL2 to a specific region of the genome containing one or several genes poised for activation. Subsequent spreading would then permit the inactive MLL2 methyltransferase to scan neighboring chromatin until reaching activation signals (e.g., specific cofactors, phosphorylated pol II, and/or acetylated H3K9) present only at the gene coding regions.
Is the ''Spreading'' of MLL2 Specific to the b-Globin Locus? Recruitment of transcription factors to the b-globin LCR followed by long-range ''transfer'' to the b-globin genes is not without precedent. For example, Pol II is recruited to the LCR (in a NF-E2/p45-independent manner) before being transported to the b-globin genes (in a NF-E2/p45-dependent manner) (Johnson et al., 2001) . Communication between the LCR and the active b-globin genes is generally thought to occur via a ''looping'' mechanism whereby the LCR and the b-globin genes come into direct physical contact through their interacting proteins and the intervening DNA sequences are looped out (Dean, 2006; Li et al., 2006; Tolhuis et al., 2002) . Although this mechanism may be important for some instances of crosstalk between the LCR and the b-globin genes, our results suggest that transfer of the MLL2 protein follows a previously proposed ''linking'' mechanism whereby communication between the LCR and the b-globin genes occurs via spreading of proteins along the locus (Bulger and Groudine, 1999) . Indeed, in differentiated erythroid cells, MLL2 binding clearly extends from the LCR to the coding region of the active b maj -globin gene, spanning regions of DNA that would generally be considered to be looped out in the ''looping'' model (Tolhuis et al., 2002) . Thus, our results provide experimental evidence that spreading of a transcription factor indeed occurs between the LCR and the b maj -globin gene, suggesting a mechanism other than looping for long-distance transfer of transcription factors. This model is likely to extend beyond b-globin gene regulation. For example, the developmentally regulated clustered Hox genes (Krumlauf, 1994) display several similarities with the b-globin genes. First, genome-wide location analysis of MLL1 revealed that, in contrast to many active genes where MLL1 is restricted to a region immediately adjacent to transcription start sites, MLL1 binding to the HoxA cluster extends significantly in both directions from the transcription start site (at least 3.7 kb downstream and 2.2 kb upstream of individual Hox genes) and is distributed across the entire coding region of the genes (Guenther et al., 2005; Milne et al., 2005b) . We also observe MLL2 spreading away from the LCR, across 38 kb into the b maj -globin gene. Interestingly, in both the HoxA cluster (Guenther et al., 2005; Scacheri et al., 2006) and b-globin locus ( Figure 3B ), MLL1/MLL2 binding has been detected at genomic regions that are not enriched for H3K4me3. These observations suggest that the mechanism of recruitment and spreading of MLL2 that we have described at the b-globin locus might also be relevant to other developmentally regulated clustered genes such as Hox genes. Although similarities exist between the HoxA and the b-globin clusters, important differences remain between the two loci. Indeed, while the Hox A and B clusters contain broad domains of H3K4me2 regions covering multiple active genes (Bernstein et al., 2005) , the b-globin locus displays a punctate pattern for both dimethyl (Bulger et al., 2003 ; and data not shown) and trimethyl H3K4 (this study). These differences most likely arise from organizational differences between the two loci: the contiguous b-like globin genes are differentially expressed at specific developmental stages, whereas the HoxA clusters contain multiple active genes located in close proximity. Alternatively, these divergent H3K4 methylation patterns could arise from intrinsic differences between MLL1 and MLL2. However, we believe this is unlikely, because MLL1 and MLL2 methyltransferases display a high degree of similarity and interact with the same cofactors (Ruthenburg et al., 2007) . Given these similarities, it is interesting to note that, whereas MLL À/À and MLL2 À/À mice are both embryonic lethal (Ernst et al., 2004; Glaser et al., 2006; Yu et al., 1995) , MLL +/À mice are severely anemic The MLL2 complex is initially guided to the b-globin locus control region (LCR) via its interaction with the LCR-bound activator NF-E2. Binding of this H3K4 methyltransferase to the LCR does not, however, result in trimethylation of H3K4 in this region (presumably because of the histone code particular to this region of the locus). Then, MLL2 detaches from its core components and spreads across 38 kb where it reaches the elongating Pol II and associated complexes. Interaction with basal transcriptional elongation machinery and/or the presence of specific histone modifications (H3K9ac and/or ubiquitinated H2B) allows MLL2 to methylate H3K4. The inactive/active MLL2 protein is represented by a black/gray shading. H3K4me3 and H3K9ac are represented below the region where they are enriched on the b-globin locus, and the direction of their variation during differentiation is figured by arrows. (Yu et al., 1995) . It will be interesting to determine whether a similar erythroid phenotype is observed in the MLL2 +/À mice. Proteomic analysis of NF-E2/p45 interacting proteins has allowed us to identify a previously undefined mechanism by which the LCR regulates b-globin gene expression and chromatin structure at a distance during terminal erythroid differentiation. Continued analysis of protein complexes associated with the LCR should permit further insight into the mechanisms regulating developmental gene expression.
EXPERIMENTAL PROCEDURES
Antibodies
Abs used for western blot. From Santa Cruz Biotechnology, we used anti-NF-E2/p45 (sc-291), -CBP (sc-369), -MAFK (sc-477), and -TF II . From Bethyl Laboratories, we used anti-MLL2/ TRX2 (BL-835), -RbBP5 (BL-766), and MENIN (BL-342). From Upstate Biotechnology, we used anti-SAP30 (06-875). Polyclonal Abs against NF-E2/p45 (# 945) and ASH2L (# 1025) were generated in rabbits by means of purified full-length proteins. WDR5 and HP1g Abs were gifts from W. Herr and R. Losson, respectively.
Abs used for IP and ChIP are the same except for ASH2L (# 907). From Upstate Biotechnology, we used anti-H3K9ac (07-352). From Abcam, we used anti-H3K4me3 (ab-8580). From Santa Cruz Biotechnology, we used the normal rabbit IgG (sc-2027).
Cell Culture, Immunoprecipitation, and Quantitative Mass Spectrometry MEL (clone 745) and CB3 cells were cultured in RPMI containing 10% serum, 1% glutamine, and antibiotics. An expression vector encoding NF-E2/p45 (Kotkow and Orkin, 1995) was stably transfected into the CB3 cell line, and clones expressing NF-E2/p45 were selected in 1 mg/ml G418. CB3 and CB3+p45 clones were induced to differentiate along the erythroid lineage by adding 1.5% final DMSO for 3 days. MEL cells were induced to differentiate along the erythroid lineage by adding 2% final DMSO for 3 days and nuclear extracts were prepared as previously described (Brand et al., 2004) . Anti-NF-E2/p45, -ASH2L, and -MLL2 IPs were performed as described (Brand et al., 2004) with the following modifications. Abs crosslinked to Dynabeads-protein A (Dynal) were used for IP. Elution of the proteins was performed at 37 C in 50% acetonitrile containing 0.1% TFA. Eluted proteins were labeled with the isotopically labeled ICAT reagents and identified and relatively quantified by mass spectrometry as described previously (Ranish et al., 2007) . The probability of identification was determined for each protein using the PeptideProphet and ProteinProphet algorithms (Nesvizhskii et al., 2003) .
Chromatin Immunoprecipitation
ChIP assays were performed as previously described (Brand et al., 2004) except that sonication was done with a Bioruptor (Diagenode). Real-time qPCR analysis was done on a ABI Prism 7500 detector with Taqman probes and primers (sequences available in the Supplemental Data). To calculate the enrichment of each protein to a particular target DNA, values obtained (via the standard curve method) for each target were divided by the amount of the corresponding target in the input fraction. Enrichments obtained from mock IPs performed in parallel with normal IgG were then subtracted from the enrichment values obtained with specific Abs. All the enrichments are expressed as a function of the highest enrichment obtained on the locus (set to 1).
Methyltransferase Assays NF-E2/p45-, Mock-, or MLL2-associated proteins were isolated on beads and incubated with 1 mg/ml purified core histones (Roche) or nucleosomes (prepared as described in Brand et al., 1999) No Dox Dox
